Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Gerald Aggrey

Adult Reconstructive Orthopaedic Surgery Eugene, OR Medical Doctor

NPI 1639564065 CMS profile 8415629

55 Coburg Rd, Eugene, OR 97401

Open in the dashboard

General payments

$8,717

63 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gerald Aggrey of Eugene, OR is reported in the CMS Open Payments database as having received $8,717 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $577 7
2024 General $3,367 17
2023 General $2,002 15
2022 General $1,710 15
2021 General $783 4
2020 General $277 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gerald Aggrey
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Gerald Aggrey were reported at $577. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Gerald Aggrey Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $0 $1,416 $292–$9,336 $163
2020 $277 $647 $141–$6,474 $114
2021 $783 $1,073 $211–$6,497 $132
2022 $1,710 $1,217 $236–$6,299 $149
2023 $2,002 $1,082 $246–$6,818 $160
2024 $3,367 $1,575 $323–$8,944 $164
2025 $577 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Stryker Corporation $4,283 31 payments
  2. Zimmer Biomet Holdings, Inc. $3,616 19 payments
  3. Orthalign Inc $240 2 payments
  4. DePuy Synthes Sales Inc. $218 4 payments
  5. Onkos Surgical, Inc. $113 1 payment
  6. Wildwood Medical LLC $71 1 payment
  7. Heron Therapeutics, Inc. $62 1 payment
  8. FX Shoulder USA, Inc $45 1 payment
  9. Heraeus Medical, LLC. $25 1 payment
  10. Pacira Pharmaceuticals Incorporated $24 1 payment
  11. Other $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $4,504 47 payments
  2. Travel and Lodging $4,212 16 payments
Products named General payments · program years 2020–2025
  1. MAKO $3,211 24 payments
  2. Persona $1,227 7 payments
  3. MOTIONSENSE DIGITAL GONIOMETER $744 4 payments
  4. ROSA $325 3 payments
  5. Arcos $254 2 payments
  6. ORTHALIGN PLUS $240 2 payments
  7. TRIATHLON $150 1 payment
  8. OSS Orthopedic Salvage System $146 1 payment
  9. NexGen $146 1 payment
  10. SURG - SYSTEM 8 $122 1 payment
  11. Other $695 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

458

Median for Orthopedic Surgery: 203

Drug cost

$2,569

Median for Orthopedic Surgery: $1,433

Branded share of claims

8.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 266 $933
Diclofenac Sodium Generic 25 $497
Oxycodone Hcl Generic 42 $372
Ondansetron Odt Ondansetron Brand 38 $334
Mupirocin Generic 20 $172
Celecoxib Generic 16 $139
Tramadol Hcl Generic 31 $87
Prednisone Generic 20 $35

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$78,096

Of which drugs: $1,182

Medicare patients

265

Average age 74

Services billed

948

169 women, 96 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Depression 23%
Diabetes 22%
Chronic kidney disease 18%
Ischemic heart disease 16%
Atrial fibrillation 14%
Osteoporosis 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 46 224 $157

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record